RSG
77
4
MU
32
-6
ADI
45
-5
RCL
88
-2
XRX
34
-3
QCOM
55
-2
PSA
58
5
CHRW
67
3
MS
80
-3
GLW
48
-5
R
77
2
CTSH
65
-3
EXPE
96
-3
QRVO
4
-2
SLB
56
-3
HCP
70
-4
CI
52
-7
WHR
70
4
SE
60
-5
PNR
74
5
RSG
77
4
MU
32
-6
ADI
45
-5
RCL
88
-2
XRX
34
-3
QCOM
55
-2
PSA
58
5
CHRW
67
3
MS
80
-3
GLW
48
-5
R
77
2
CTSH
65
-3
EXPE
96
-3
QRVO
4
-2
SLB
56
-3
HCP
70
-4
CI
52
-7
WHR
70
4
SE
60
-5
PNR
74
5
Financhill
Back

Cytokinetics Stock Price Chart

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
53

CYTK
Cytokinetics

Last Price:
54.71
Seasonality Move:
9.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.
  • The current trend is moderately bullish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

Cytokinetics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 55.91 Sell
20-day SMA: 53.86 Buy
50-day SMA: 54.19 Buy
200-day SMA: 60.4 Sell
8-day EMA: 55.45 Sell
20-day EMA: 54.59 Buy
50-day EMA: 54.52 Buy
200-day EMA: 55.64 Sell

Cytokinetics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.58 Buy
Relative Strength Index (14 RSI): 50.96 Buy
Chaikin Money Flow: -747981 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.94 - 56.1) Buy
Bollinger Bands (100): (53.08 - 57.16) Sell

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cytokinetics Stock

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 54.70 while CYTK 8-day simple moving average is 55.91, which is a Sell signal.
  • The stock price of CYTK is 54.70 while Cytokinetics 20-day SMA is 53.86, which makes it a Buy.
  • Cytokinetics 50-day simple moving average is 54.19 while CYTK share price is 54.70, making it a Buy technically.
  • CYTK stock price is 54.70 and Cytokinetics 200-day simple moving average is 60.40, creating a Sell signal.

CYTK Technical Analysis vs Fundamental Analysis

Buy
53
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy or a Sell?

  • Cytokinetics stock is rated a Buy
    The current Cytokinetics [CYTK] share price is $54.70. The Score for CYTK is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.

Cytokinetics Stock Info

Market Cap:
6.46B
Price in USD:
54.70
Share Volume:
896.05K

Cytokinetics 52-Week Range

52-Week High:
110.25
52-Week Low:
30.68
Buy
53
Cytokinetics (CYTK) is a Buy

Cytokinetics Share Price Forecast

  • What is the Cytokinetics stock price today?
    The Cytokinetics stock price is 54.70 USD today.
  • Will CYTK stock go up or go down?
    Cytokinetics> share price is forecast to RISE/FALL based on technical indicators
  • Is Cytokinetics overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cytokinetics is not overvalued.

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 54.70 while CYTK 8-day exponential moving average is 55.45, which is a Sell signal.
  • The stock price of CYTK is 54.70 while Cytokinetics 20-day EMA is 54.59, which makes it a Buy.
  • Cytokinetics 50-day exponential moving average is 54.52 while CYTK share price is 54.70, making it a Buy technically.
  • CYTK stock price is 54.70 and Cytokinetics 200-day simple moving average is 55.64, creating a Sell signal.

Fundamental Analysis of Cytokinetics

Is Cytokinetics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $0.11 per share.

Technical Analysis of Cytokinetics

Should I short Cytokinetics stock?

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.